Hurley Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$231K Hold
199
– – 0.11% 92
2026
Q2
$238K Buy
199
+67
+51% +$68.5K 0.12% 86
2026
Q1
$122K Buy
132
+1
+0.8% +$1.01K 0.07% 115
2025
Q4
$141K Buy
131
+3
+2% +$2.87K 0.08% 104
2025
Q3
$97.9K Buy
128
+14
+12% +$10.4K 0.06% 136
2025
Q2
$89K Buy
114
+11
+11% +$8.55K 0.06% 117
2025
Q1
$85.2K Sell
103
-100
-49% -$83.2K 0.06% 129
2024
Q4
$162K Buy
+203
New +$168K 0.13% 78

Other funds holding LLY

Hurley Capital's LLY Position: Q3 2026 in Review

Hurley Capital held its Eli Lilly (LLY) position steady in Q3 2026 at 199 shares worth $231K. The position accounts for 0.11% of the portfolio, ranked #92.

Hurley Capital first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $238K in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Hurley Capital held 199 shares of Eli Lilly worth $231K as of Q3 2026.
  • Hurley Capital left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.11% of Hurley Capital's portfolio in Q3 2026, its #92 holding.
  • Hurley Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • Hurley Capital's Eli Lilly position peaked at $238K in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Hurley Capital's 13F filing for Q3 2026, filed 5 Nov 2026.